. . . . . . . . . . . . . . . . . . . . . . . . . . "complex(p(HGNC:ASB3),p(HGNC:TNFRSF1B)) -| (p(HGNC:TNFRSF1B) -> kin(p(HGNC:MAPK8)))" . "p(HGNC:TNFRSF1B) -> kin(p(HGNC:MAPK8))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Selventa" . "ASB3 expression and activities are required for (i) TNF-R2 ubiquitination both in vivo and in vitro, (ii) TNF-R2 proteolysis via the proteasome pathway, and (iii) the inhibition of TNF-R2-mediated Jun N-terminal protein kinase (JNK) activation." . . . . . "2014-07-03T14:30:35.434+02:00"^^ . . .